Clinical Trial

Glucokinase Activator in Monogenic Diabetes

Name: Glucokinase Activator in Monogenic Diabetes — clinical trial record (NCT06976658)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RESENSE

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

Evaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-05-14.

Status change: Not Yet Recruiting → Recruiting 2026-04-25

Trial Details

NCT Number	NCT06976658
Lead Sponsor	Chinese University of Hong Kong
Conditions	Diabetes Mellitus, Monogenic Diabetes
Enrollment	44 participants
Start Date	2025-04-30
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-30